360° Coverage : What Are Bidis And Why Is The FDA Regulating Tobacco Products?

2 Updates

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed...

Filed under: news

 
 
 

34 weeks ago

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed to cease U.S. import, distribution, and sales of four brands of bidis, a tobacco smoking product that’s rolled in the leaves of the tendu plant, instead of paper, then tied with string. The specific bidi products are sold as Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone, and Sutra Bidis Menthol Cone.

An article in The Times of India suggests that Jash International is not a particularly well-known company in its home country, so this first FDA warning might be serving as a shakedown cruise for exercising their regulatory might. The company was cited for not registering their products with the FDA, an application that would likely have been turned down anyway since bidis do not meet the standards of having a “predicate product” sold in the U.S. as of February 15, 2007. What that means is that tobacco products sold as of that date serve as the standard to which new tobacco products are compared with for “substantial equivalence.”

The Act has been criticized in some circles as protecting the large tobacco manufacturers whose previously marketed products serve as such standards.

The FDA’s CTP order results from the authority provided under the Family Smoking Prevention and Tobacco Control Act of 2009, “to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.”

Several local folks I spoke with were not aware that the FDA had regulatory authority of tobacco products, certainly not since 2009. A typical response is “Why would FDA regulate a potentially lethal product?” Indeed, use of tobacco products results in over 440,000 death per year in the U.S. alone.

In the briefest possible terms, the FDA Center for Tobacco Products takes a harm reduction approach to tobacco use in the U.S. The Act established the CTP’s mission as three-fold: 1) to prevent Americans—especially youth—from starting to use tobacco, 2) encourage current users to quit, and 3) decrease the harms of tobacco product use.

To accomplish this mission, the CTP has the authority to require tobacco companies to register their products with the FDA, disclose the content of the product, including nicotine and tar content, limit how tobacco is distributed and sold, and review new tobacco products before they are marketed. Of course, this is one activity where the FDA does not require proof of efficacy or safety. Rather, the products are being regulated to minimize their health risks for Americans who choose to continue smoking.

A major effort is directed at minimizing tobacco sales and promotion to minors, including a ban on all candy and fruit-type flavorings other than menthol. The special dispensation of menthol was a sticking point during legislative deliberations since its inclusion in cigarettes appeals disproportionate to minority groups and causes smoke to be inhaled more deeply into the lungs.

Interestingly, the Act only applies to manufactured or hand-rolled cigarettes, the tobacco used therein, and smokeless tobacco. Cigars do not fall under the Act, nor do the increasingly popular nicotine delivery devices, e-cigarettes.

However, a “Unified Agenda” statement from the FDA and the U.S. Department of Health and Human Services was published in Fall 2013 to give the CTP authority to regulate, “hookah, electronic cigarettes, cigars, pipe tobacco, other novel tobacco products, and future tobacco products.”

The Act represents the compromise from a long battle for complete prohibition of tobacco products that began with the FDA commissioner tenure of Dr. David Kessler from 1990 to 1997.

Kessler documents the history of tobacco regulation in a highly-readable and sometimes suspenseful 2002 book, “A Question of Intent: A Great American Battle With A Deadly Industry.” A Johns Hopkins-trained pediatrician with a University of Chicago law degree, Kessler was not new to politics. He had served as an advisor to Senator Orrin Hatch (R-Utah), who described him in 1991 as, “one of the brightest, most decent men I know.” Kessler had also taught food and drug law at Columbia.

Kessler is well-known to Forbes Pharma & Healthcare readers since his one of his major contributions was to accelerate the pace at which the FDA reviewed and approved pharmaceuticals. Among his accomplishment was to enable the agency to use surrogate endpoints of efficacy as the basis for approval of drugs to treat serious, life-threatening diseases. For example, an increase in CD4+ T lymphocytes was used as a surrogate marker of efficacy of HIV reverse transcriptase inhibitors instead of, say, five-year patient survival.

But Kessler also felt that if nicotine was a drug – which it is in pharmacological terms – and that the FDA regulates all chemicals that come in contact with our bodies, that the FDA should regulate tobacco products. While he was not successful at the time, his efforts carried on as social stigma to tobacco smoke grew across the U.S., even in tobacco-growing states like North Carolina (from where this post has been written).

Passage of the Family Smoking Prevention and Tobacco Control Act of 2009, garnered both bipartisan support, the endorsement of the American Cancer Society and American Heart Association, as well as the endorsement of major tobacco companies. The Act continues to raise concerns as to the ethics of a regulatory safety agency should continue to allow sales of products know to still be the leading cause of death in the United States.

But the Center for Tobacco Products also allows for training and development of policies in this arena. In fact, interested mid-career investigators might care to apply for the third class of FDA-CTP-Institute of Medicine fellowships in tobacco regulatory science. You have one week to send your application in – the deadline is March 3, 2014. Application information is here.

Source: Forbes Business

 
Update
2

7 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the wo ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

8 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedie ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Twitter declares war on passwords
San Francisco, Oct 24 (IANS/EFE) Twitter formally declared war on passwords during a developers' conference in San Francisco, unveiling a new system that allows users to log-in to mobile apps with a phone number.
 
 
Ebola not to upset Africa's overall growth: IMF
Harare, Oct 23 (IANS) The Ebola outbreak in West Africa, which has claimed 4,500 lives, will have minimum impact on continent's overall growth, a top International Monetary Fund (IMF) official said Thursday.
 
 
Second MERS case reported in Qatar
Doha, Oct 23 (IANS) A 43-year-old man in Qatar has tested positive for Middle East Respiratory Syndrome (MERS) in the second confirmed case of the deadly virus in 10 days, media reported Thursday.
 
 
OPEC daily basket price falls again
Vienna, Oct 23 (IANS/WAM) The basket of 12 crude oils of the Organization of Petroleum Exporting Countries (OPEC) closed at $81.94 a barrel Wednesday compared to $82.09 Tuesday, the OPEC Secretariat said.
 
 
 

Latest from the Network

Second MERS case reported in Qatar
Doha, Oct 23 (IANS) A 43-year-old man in Qatar has tested positive for Middle East Respiratory Syndrome (MERS) in the second confirmed case of the deadly virus in 10 days, media reported Thursday. The patient had...
Read more on Business Balla
 
Two people die in Pakistan bomb blast
Islamabad, Oct 23 (IANS) At least two people were killed and 12 others injured in an explosion that took place in Pakistan's Balochistan province Thursday, media reported. The bomb was planted on a motorcycle, Dawn...
Read more on Politics Balla
 
Trott extends contract with Warwickshire till 2017
London, Oct 23 (IANS) England batsman Jonathan Trott, whose mental issues led to his abrupt departure from last winter's Ashes tour, has confirmed his successful comeback to competitive cricket by signing a new three-...
Read more on Sport Balla
 
Srikanth, Kashyap big movers in BWF rankings
Kuala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest Badminton World Federation (BWF) rankings released Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Alvin Stardust dead
London, Oct 23 (IANS) English singer Alvin Stardust died after a short illness. He was 72. Stardust's manager confirmed the news about his demise Thursday, reports mirror.co.uk. He was recently diagnosed with...
Read more on Celebrity Balla
 
Indian man reunited with family after 40 years
Dubai, Oct 23 (IANS) An Indian man, who had disappeared from his hometown in Kerala nearly 40 years ago, has been found by his family at a hospital in Dubai in the UAE, a newspaper report said. Now in his 60s, Abdulla...
Read more on Politics Balla
 
Srikanth, Kashyap, Saina rise in world rankings
Kala Lumpur, Oct 23 (IANS) Indian men shuttlers Kidambi Srikanth and Parupalli Kashyap jumped seven places each in the latest released Badminton World Federation (BWF) rankings Thursday while Olympic bronze medallist...
Read more on Sport Balla
 
Flintoff signs for Big Bash side Brisbane Heat
Brisbane, Oct 23 (IANS) Former England captain and all-rounder Andrew Flintoff, who retired from international cricket in 2009, Wednesday confirmed that he will play for Brisbane Heat in the Big Bash League (BBL) this...
Read more on Sport Balla
 
OPEC daily basket price falls again
Vienna, Oct 23 (IANS/WAM) The basket of 12 crude oils of the Organization of Petroleum Exporting Countries (OPEC) closed at $81.94 a barrel Wednesday compared to $82.09 Tuesday, the OPEC Secretariat said. The new OPEC...
Read more on Business Balla
 
Lopez to sign multi-million dollar deal?
Los Angeles, Oct 23 (IANS) Singer-actress Jennifer Lopez is reportedly in the final stages of securing a multi-million dollar deal to perform in Las Vegas. The 45-year-old is being offered $350,000 per show at The...
Read more on Celebrity Balla